Ipca Laboratories Ltd
NSE :IPCALAB BSE :524494 Sector : PharmaceuticalsBuy, Sell or Hold IPCALAB? Ask The Analyst
BSE
Apr 09, 00:00
1296.25
-67.70 (-4.96%)
prev close
1363.95
OPEN PRICE
1345.05
volume
8937
Today's low / high
1270.00 / 1345.05
52 WK low / high
1060.95 / 1757.65
bid price (qty)
0 (0)
offer price (qty)
0 (0)
NSE
Apr 09, 00:00
1294.85
-64.70 (-4.76%)
prev close
1359.55
open price
1343.55
volume
425780
Today's' low / high
1270.00 / 1349.80
52 WK low / high
1052.00 / 1755.90
bid price (qty)
1294.85 (94)
offer price (qty)
0 (0)
08 Apr 1359.55 (4.50%) | 07 Apr 1301.05 (-7.02%) | 04 Apr 1399.25 (-6.57%) | 03 Apr 1497.60 (5.77%) | 02 Apr 1415.95 (1.80%) | 01 Apr 1390.85 (-7.39%) | 28 Mar 1501.90 (2.17%) | 27 Mar 1470.05 (2.57%) | 26 Mar 1433.25 (-0.93%) | 25 Mar 1446.75 (-0.43%) | 24 Mar 1453.00 (3.27%) | 21 Mar 1407.05 (0.35%) | 20 Mar 1402.20 (3.16%) | 19 Mar 1359.30 (0.91%) | 18 Mar 1347.05 (2.23%) | 17 Mar 1317.70 (1.42%) | 13 Mar 1299.30 (-1.27%) | 12 Mar 1315.95 (1.70%) | 11 Mar 1294.00 (-2.49%) | 10 Mar 1327.00 (-0.46%) | 07 Mar 1333.10 (-2.13%) |
Technical Analysis
Short Term Investors

Neutral
Medium Term Investors

Very Bearish
Long Term Investors

Very Bearish
Moving Averages
5 DMA
Bearish
1395.41
10 DMA
Bearish
1423.39
20 DMA
Bearish
1387.27
50 DMA
Bearish
1413.33
100 DMA
Bearish
1497.84
200 DMA
Bearish
1449.32
Intraday Support and Resistance
(Based on Pivot Points) NSE : 1294.85 | BSE : 1296.25
Updated On Apr 08, 2025 04:00 PM For Next Trading Session
Pivots | Classic | Fibonacci | Camarilla | Woodie | DM |
---|---|---|---|---|---|
R3 | 1444.21 | 1405.88 | 1376.46 | - | - |
R2 | 1405.88 | 1382.39 | 1370.83 | 1409.68 | - |
R1 | 1382.71 | 1367.87 | 1365.19 | 1390.31 | 1394.3 |
P | 1344.38 | 1344.38 | 1344.38 | 1348.18 | 1350.18 |
S1 | 1321.21 | 1320.89 | 1353.91 | 1328.81 | 1332.8 |
S2 | 1282.88 | 1306.37 | 1348.28 | 1286.68 | - |
S3 | 1259.71 | 1282.88 | 1342.64 | - | - |
Key Metrics
EPS
32.66
P/E
41.76
P/B
5.14
Dividend Yield
0.29%
Market Cap
34,492 Cr.
Face Value
1
Book Value
265.61
ROE
8.69%
EBITDA Growth
482.19 Cr.
Debt/Equity
0.24
Shareholding History
Quarterly Result (Figures in Rs. Crores)
Ipca Laboratories Ltd Quaterly Results
Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | ||
INCOME | 2143.76 | 2051.95 | 2113.24 | 2381.16 | 2265.48 | |
PROFIT | 127.19 | 122.62 | 192.24 | 229.48 | 248.14 | |
EPS | 7.09 | 2.35 | 7.58 | 9.05 | 9.78 |
Ipca Laboratories Ltd Quaterly Results
Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | ||
INCOME | 1524.16 | 1525.72 | 1581.25 | 1827.94 | 1680.09 | |
PROFIT | 136.63 | 112.74 | 204.13 | 244.12 | 267.56 | |
EPS | 5.4 | 2.55 | 8.05 | 9.62 | 10.55 |
Profit & Loss (Figures in Rs. Crores)
Ipca Laboratories Ltd Profit & Loss
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
INCOME | 3245.02 | 2863.48 | 3174.46 | 3276.05 | 3918.79 | 4862.15 | 5677.62 | 6026.01 | 6269.27 | 8028.46 | |
PROFIT | 249.95 | 88.69 | 191.73 | 234.38 | 438.99 | 596.85 | 1134.03 | 885.33 | 454.16 | 593.55 | |
EPS | 10.27 | 3.81 | 7.71 | 9.49 | 17.5 | 23.89 | 45.29 | 35.91 | 19.39 | 20.86 |
Ipca Laboratories Ltd Profit & Loss
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
INCOME | 3188.27 | 2809.07 | 3124.59 | 3211.96 | 3766.39 | 4557.56 | 5372.13 | 5617.22 | 5821.72 | 6332.94 | |
PROFIT | 251.84 | 88.89 | 185.45 | 228.18 | 448.61 | 641.6 | 1132.43 | 852.51 | 488.19 | 599.93 | |
EPS | 10.15 | 3.67 | 7.46 | 9.24 | 18 | 25.82 | 44.97 | 33.91 | 19.93 | 20.91 |
Balance Sheet (Figures in Rs. Crores)
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 25.37 | 25.37 | 25.37 | 25.37 | 25.27 | 25.27 | 25.24 | 25.24 | 25.24 | 25.24 |
Reserves Total | 6,306.82 | 5,816.65 | 5,439.47 | 4,676.28 | 3,590.27 | 3,097.12 | 2,663.33 | 2,430.02 | 2,233.95 | 2,183.19 |
Equity Share Warrants | 0 | 0 | 0 | 0 | 11.94 | 0 | 0 | 0 | 0 | 0 |
Total Shareholders Funds | 6,332.19 | 5,842.02 | 5,464.84 | 4,701.65 | 3,627.48 | 3,122.39 | 2,688.57 | 2,455.26 | 2,259.19 | 2,208.43 |
Minority Interest | 1,394.81 | 73.3 | 76.92 | 14.53 | 13.63 | 15.54 | 0 | 0 | 0 | 0 |
Secured Loans | 1,209.68 | 857.91 | 554.57 | 140.92 | 324.46 | 444.21 | 622.21 | 656.3 | 738.61 | 759.08 |
Unsecured Loans | 228.68 | 623.36 | 252.65 | 124.47 | 176.26 | 20.74 | 5.35 | 59.45 | 128.57 | 175.91 |
Total Debt | 1,438.36 | 1,481.27 | 807.22 | 265.39 | 500.72 | 464.95 | 627.56 | 715.75 | 867.18 | 934.99 |
Other Liabilities | 87.83 | 47.27 | 44.83 | 40.71 | 34.49 | 26.84 | 27.44 | 26.11 | 21.84 | 22.05 |
Total Liabilities | 9,253.19 | 7,443.86 | 6,393.81 | 5,022.28 | 4,176.32 | 3,629.72 | 3,343.57 | 3,197.12 | 3,148.21 | 3,165.47 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 7,020.79 | 4,364.66 | 3,743.48 | 3,212.19 | 2,985.73 | 2,632.86 | 2,464.33 | 2,318.22 | 2,176.95 | 2,546.33 |
Less: Accumulated Depreciation | 2,467.26 | 1,613.28 | 1,341.29 | 1,139.76 | 927 | 692.48 | 511.37 | 334.95 | 162.77 | 745.9 |
Net Block | 4,553.53 | 2,751.38 | 2,402.19 | 2,072.43 | 2,058.73 | 1,940.38 | 1,952.96 | 1,983.27 | 2,014.18 | 1,800.43 |
Capital Work in Progress | 342.89 | 140.43 | 306.43 | 234.82 | 133.28 | 66.33 | 73 | 94.64 | 128.74 | 267.22 |
Investments | 862.01 | 625.98 | 989.19 | 505.26 | 309.56 | 120.43 | 86.87 | 135.81 | 25.82 | 16.19 |
Inventories | 2,471.31 | 1,743.37 | 1,857.97 | 1,594.81 | 1,323.12 | 1,072.5 | 880.59 | 882.22 | 837.42 | 926.56 |
Sundry Debtors | 1,686.51 | 989.02 | 910.78 | 811.75 | 895.2 | 681.51 | 602.27 | 500.16 | 445.87 | 353 |
Cash and Bank Balance | 296.84 | 1,853.24 | 640.66 | 365.07 | 180.92 | 282.3 | 150.57 | 35.85 | 175.54 | 124.79 |
Loans and Advances | 525.84 | 280.32 | 317.99 | 271.5 | 218.22 | 251.06 | 242.7 | 210.02 | 163.09 | 209.63 |
Total Current Assets | 4,980.5 | 4,865.95 | 3,727.4 | 3,043.13 | 2,617.46 | 2,287.37 | 1,876.13 | 1,628.25 | 1,621.92 | 1,613.98 |
Current Liabilities | 1,249.92 | 862.62 | 945.49 | 797.95 | 840.64 | 684.65 | 535.71 | 526.24 | 520.55 | 436.6 |
Provisions | 287.7 | 130.79 | 119.85 | 114.58 | 101.05 | 88.75 | 78.31 | 65.68 | 66.49 | 35.98 |
Total Current Liabilities & Provisions | 1,537.62 | 993.41 | 1,065.34 | 912.53 | 941.69 | 773.4 | 614.02 | 591.92 | 587.04 | 472.58 |
Net Current Assets | 3,442.88 | 3,872.54 | 2,662.06 | 2,130.6 | 1,675.77 | 1,513.97 | 1,262.11 | 1,036.33 | 1,034.88 | 1,141.4 |
Deferred Tax Assets | 122.82 | 22.25 | 103.53 | 90.39 | 87.51 | 85.26 | 74.49 | 57.91 | 55.65 | 9.57 |
Deferred Tax Liability | 429.06 | 207.84 | 265.89 | 221.99 | 227.32 | 230.97 | 232.46 | 228.38 | 212.11 | 183.88 |
Net Deferred Tax | -306.24 | -185.59 | -162.36 | -131.6 | -139.81 | -145.71 | -157.97 | -170.47 | -156.46 | -174.31 |
Other Assets | 358.12 | 239.12 | 196.3 | 210.77 | 138.79 | 134.32 | 126.6 | 117.54 | 101.05 | 114.54 |
Total Assets | 9,253.19 | 7,443.86 | 6,393.81 | 5,022.28 | 4,176.32 | 3,629.72 | 3,343.57 | 3,197.12 | 3,148.21 | 3,165.47 |
Contingent Liabilities | 129.45 | 152.23 | 69.67 | 55.76 | 42.08 | 40.4 | 43.05 | 45.54 | 47.56 | 255.38 |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 25.37 | 25.37 | 25.37 | 25.37 | 25.27 | 25.27 | 25.24 | 25.24 | 25.24 | 25.24 |
Reserves Total | 6,323.34 | 5,851.93 | 5,450.39 | 4,727.35 | 3,640.33 | 3,111.39 | 2,669.71 | 2,449.88 | 2,257.81 | 2,208.09 |
Equity Share Warrants | 0 | 0 | 0 | 0 | 11.94 | 0 | 0 | 0 | 0 | 0 |
Total Shareholders Funds | 6,348.71 | 5,877.3 | 5,475.76 | 4,752.72 | 3,677.54 | 3,136.66 | 2,694.95 | 2,475.12 | 2,283.05 | 2,233.33 |
Secured Loans | 990.54 | 857.91 | 554.57 | 113.53 | 298.19 | 444.21 | 622.21 | 666.3 | 736.62 | 754.71 |
Unsecured Loans | 161.28 | 582.47 | 221.84 | 122.72 | 176.26 | 0 | 5.35 | 49.45 | 128.58 | 174.1 |
Total Debt | 1,151.82 | 1,440.38 | 776.41 | 236.25 | 474.45 | 444.21 | 627.56 | 715.75 | 865.2 | 928.81 |
Other Liabilities | 50.61 | 46.85 | 44.33 | 39.44 | 33.24 | 26.84 | 27.44 | 26.11 | 21.78 | 20.87 |
Total Liabilities | 7,551.14 | 7,364.53 | 6,296.5 | 5,028.41 | 4,185.23 | 3,607.71 | 3,349.95 | 3,216.98 | 3,170.03 | 3,183.01 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 4,165.82 | 3,889.09 | 3,364.68 | 2,899.27 | 2,688.79 | 2,412.97 | 2,358.72 | 2,276.99 | 2,137.32 | 2,465.9 |
Less : Accumulated Depreciation | 1,642.12 | 1,410.43 | 1,211.59 | 1,030.67 | 847.82 | 672.87 | 504.11 | 331.02 | 160.74 | 712.94 |
Net Block | 2,523.7 | 2,478.66 | 2,153.09 | 1,868.6 | 1,840.97 | 1,740.1 | 1,854.61 | 1,945.97 | 1,976.58 | 1,752.96 |
Capital Work in Progress | 175.2 | 123.02 | 297.15 | 182 | 84.19 | 65.96 | 73.23 | 94.87 | 128.93 | 266.95 |
Investments | 2,654.16 | 1,056.73 | 1,338.7 | 867.84 | 648.72 | 322.24 | 215.63 | 211.58 | 97.43 | 81.86 |
Inventories | 1,677.09 | 1,660.13 | 1,779.54 | 1,517.09 | 1,266.96 | 1,055.55 | 873.17 | 873.54 | 831.93 | 916.98 |
Sundry Debtors | 1,027.4 | 925.9 | 824.3 | 774.46 | 839.13 | 632.06 | 594.38 | 501.98 | 441.45 | 353.55 |
Cash and Bank Balance | 112.92 | 1,706.06 | 595.5 | 306.92 | 152.4 | 259.81 | 131.03 | 17.53 | 161.98 | 113.19 |
Loans and Advances | 281.88 | 259.74 | 305.81 | 285.49 | 215.37 | 247.75 | 239.24 | 205.03 | 164.41 | 209.34 |
Total Current Assets | 3,099.29 | 4,551.83 | 3,505.15 | 2,883.96 | 2,473.86 | 2,195.17 | 1,837.82 | 1,598.08 | 1,599.77 | 1,593.06 |
Current Liabilities | 782.48 | 773.37 | 866.28 | 733.57 | 758.95 | 616.62 | 522.24 | 516.7 | 513.27 | 431.06 |
Provisions | 142.56 | 129.62 | 117.15 | 113.15 | 99.6 | 86.95 | 76.86 | 65.63 | 65.69 | 35.44 |
Total Current Liabilities & Provisions | 925.04 | 902.99 | 983.43 | 846.72 | 858.55 | 703.57 | 599.1 | 582.33 | 578.96 | 466.5 |
Net Current Assets | 2,174.25 | 3,648.84 | 2,521.72 | 2,037.24 | 1,615.31 | 1,491.6 | 1,238.72 | 1,015.75 | 1,020.81 | 1,126.56 |
Deferred Tax Assets | 23.17 | 18.52 | 101.48 | 88.44 | 85.5 | 83.42 | 75.43 | 57.9 | 55.65 | 9.57 |
Deferred Tax Liability | 206.26 | 197.97 | 259.99 | 223.44 | 226.29 | 229.68 | 234.09 | 226.54 | 211.29 | 183.8 |
Net Deferred Tax | -183.09 | -179.45 | -158.51 | -135 | -140.79 | -146.26 | -158.66 | -168.64 | -155.64 | -174.23 |
Other Assets | 206.92 | 236.73 | 144.35 | 207.73 | 136.83 | 134.07 | 126.42 | 117.45 | 101.92 | 128.91 |
Total Assets | 7,551.14 | 7,364.53 | 6,296.5 | 5,028.41 | 4,185.23 | 3,607.71 | 3,349.95 | 3,216.98 | 3,170.03 | 3,183.01 |
Contingent Liabilities | 124.51 | 1,996.35 | 103.39 | 86.68 | 64.78 | 40.4 | 43.05 | 45.47 | 49.55 | 259.76 |
Cash Flow (Figures in Rs. Crores)
Net Profit before Tax and Extr... | 842.67 |
Depreciation | 357.24 |
Interest (Net) | 75.34 |
P/L on Sales of Assets | -3.49 |
P/L on Sales of Invest | -64.78 |
Prov. and W/O (Net) | 139.96 |
P/L in Forex | -7.2 |
Total Adjustments (PBT and Ext... | 489.87 |
Operating Profit before Workin... | 1,332.54 |
Trade and 0ther Receivables | -75.8 |
Inventories | -94.7 |
Trade Payables | 21.49 |
Total Adjustments (OP before W... | -91.59 |
Cash Generated from/(used in) ... | 1,240.95 |
Direct Taxes Paid | -296.3 |
Total Adjustments(Cash Generat... | -296.3 |
Cash Flow before Extraordinary... | 944.65 |
Net Cash from Operating Activi... | 944.65 |
Purchased of Fixed Assets | -410.6 |
Sale of Fixed Assets | 8.62 |
Sale of Investments | 64.78 |
Interest Received | 80.88 |
Investment in Group Cos. | -25.11 |
Net Cash used in Investing Act... | -1,215.29 |
Proceed from 0ther Long Term B... | 123.71 |
Of the Long Tem Borrowings | -176.76 |
Of the Short Term Borrowings | -303.83 |
Of Financial Liabilities | -10.68 |
Dividend Paid | -50.74 |
Interest Paid | -134.25 |
Net Cash used in Financing Act... | -552.55 |
Net Profit before Tax and Extr... | 822.16 |
Depreciation | 246.48 |
Interest (Net) | 64.91 |
P/L on Sales of Assets | 1.95 |
Prov. and W/O (Net) | 94.33 |
P/L in Forex | -7.11 |
Total Adjustments (PBT and Ext... | 399.16 |
Operating Profit before Workin... | 1,221.32 |
Trade and 0ther Receivables | -102 |
Inventories | -16.96 |
Trade Payables | -28.51 |
Total Adjustments (OP before W... | -113.86 |
Cash Generated from/(used in) ... | 1,107.46 |
Direct Taxes Paid | -276.95 |
Total Adjustments(Cash Generat... | -276.95 |
Cash Flow before Extraordinary... | 830.51 |
Net Cash from Operating Activi... | 830.51 |
Purchased of Fixed Assets | -360.22 |
Sale of Fixed Assets | 3.75 |
Interest Received | 72.54 |
Invest.In Subsidiaires | -1,586.17 |
Investment in Group Cos. | -25.11 |
Net Cash used in Investing Act... | -1,355.18 |
Proceed from 0ther Long Term B... | 123.71 |
Of the Long Tem Borrowings | -157.68 |
Of the Short Term Borrowings | -258.88 |
Of Financial Liabilities | -4.54 |
Dividend Paid | -50.74 |
Interest Paid | -116.75 |
Net Cash used in Financing Act... | -464.88 |
Company Details
Registered Office |
|
Address | 48 Kandivli Industrial Estate, Kandivli (West) |
City | Mumbai |
State | Maharashtra |
Pin Code | 400067 |
Tel. No. | 91-22-66474444 |
Fax. No. | 91-22-28686613 |
investors@ipca.com ; ipca@ipca.com | |
Internet | http://www.ipca.com |
Registrars |
|
Address | 48 Kandivli Industrial Estate |
City | Mumbai |
State | Maharashtra |
Pin Code | 400067 |
Tel. No. | 91-22-66474444 |
Fax. No. | 91-22-28686613 |
investors@ipca.com ; ipca@ipca.com | |
Internet | http://www.ipca.com |
Management |
|
Name | Designation |
Premchand Godha | Executive Chairman |
A K Jain | Managing Director & CFO |
Pranay Godha | Managing Director & CEO |
Prashant Godha | Executive Director |
Kamal Kishore Seth | Independent Non Exe. Director |
Narendra Mairpady | Independent Non Exe. Director |
Harish P Kamath | Company Sec. & Compli. Officer |
Swati Patankar | Independent Director |
Vivek Shiralkar | Independent Director |